-
2
-
-
0036683267
-
Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study
-
Anthonisen NR, Connett JE, Enright PL, et al. Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 333-339
-
-
Anthonisen, N.R.1
Connett, J.E.2
Enright, P.L.3
-
3
-
-
27144484127
-
Cardiovascular morbidity and mortality in COPD
-
Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.
-
(2005)
Chest
, vol.128
, pp. 2640-2646
-
-
Huiart, L.1
Ernst, P.2
Suissa, S.3
-
4
-
-
0037465734
-
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
-
Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
-
(2003)
Circulation
, vol.107
, pp. 1514-1519
-
-
Sin, D.D.1
Man, S.F.2
-
5
-
-
84878089110
-
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease
-
Undas A, Celinska-Lowenhoff M, Lowenhoff T, et al. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 2006; 4: 1029-1036.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 1029-1036
-
-
Undas, A.1
Celinska-Lowenhoff, M.2
Lowenhoff, T.3
-
6
-
-
34548096913
-
Altered fibrin clot structure in patients with advanced coronary artery disease: A role of C-reactive protein, lipoprotein(a), and homocysteine
-
Undas A, Plicner D, Stepien E, et al. Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a), and homocysteine. J Thromb Haemost 2007; 5: 1988-1990.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1988-1990
-
-
Undas, A.1
Plicner, D.2
Stepien, E.3
-
7
-
-
38349167097
-
Identification and distribution of fibrinogen, fibrin, and fibrin( ogen) degradation products in atherosclerosis
-
Bini A, Fenoglio J, Mesa-Tejada E, et al. Identification and distribution of fibrinogen, fibrin, and fibrin( ogen) degradation products in atherosclerosis. Atherosclerosis 1989; 69: 1038-1045.
-
(1989)
Atherosclerosis
, vol.69
, pp. 1038-1045
-
-
Bini, A.1
Fenoglio, J.2
Mesa-Tejada, E.3
-
8
-
-
0024457394
-
Atherosclerosis and the coagulation system
-
Thompson W, Smith E. Atherosclerosis and the coagulation system. J Pathol 1989; 159: 97-106.
-
(1989)
J Pathol
, vol.159
, pp. 97-106
-
-
Thompson, W.1
Smith, E.2
-
9
-
-
0034964447
-
The structure and biological features of fibrinogen and fibrin
-
Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci 2001; 936: 11-30.
-
(2001)
Ann NY Acad Sci
, vol.936
, pp. 11-30
-
-
Mosesson, M.W.1
Siebenlist, K.R.2
Meh, D.A.3
-
10
-
-
0028050537
-
Fibrin in human plasma: Gel architecture governed by rate and nature of fibrinogen activation
-
Blombäck B, Carlsson K, Fatah K, et al. Fibrin in human plasma: gel architecture governed by rate and nature of fibrinogen activation. Thromb Res 1994; 5: 521-538.
-
(1994)
Thromb Res
, vol.5
, pp. 521-538
-
-
Blombäck, B.1
Carlsson, K.2
Fatah, K.3
-
11
-
-
0038353228
-
Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots
-
Collet JP, Lesty C, Montalescot G,. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J Biol Chem 2003; 278: 21331-21335.
-
(2003)
J Biol Chem
, vol.278
, pp. 21331-21335
-
-
Collet, J.P.1
Lesty, C.2
Montalescot, G.3
-
12
-
-
4444376338
-
Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease
-
Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1558-1566
-
-
Scott, E.M.1
Ariëns, R.A.S.2
Grant, P.J.3
-
13
-
-
33646583539
-
Fibrin clot structure and cardiovascular disease
-
Undas A, Zeglin M. Fibrin clot structure and cardiovascular disease. Vasc Dis Prevention 2006; 3: 99-106.
-
(2006)
Vasc Dis Prevention
, vol.3
, pp. 99-106
-
-
Undas, A.1
Zeglin, M.2
-
14
-
-
33745034815
-
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects
-
Undas A, Brozek J, Jankowski M, et al. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 2006; 26: 1397-1404.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 1397-1404
-
-
Undas, A.1
Brozek, J.2
Jankowski, M.3
-
15
-
-
33645647601
-
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis
-
Undas A, Stepien E, Tracz W, et al. Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost 2006; 4: 973-975.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 973-975
-
-
Undas, A.1
Stepien, E.2
Tracz, W.3
-
16
-
-
0021266859
-
Binding of fibronectin by the acute phase C-reactive protein
-
Salonen EM, Vartio T, Hedman K. Binding of fibronectin by the acute phase C-reactive protein. J Biol Chem 1984; 259: 1496-1501.
-
(1984)
J Biol Chem
, vol.259
, pp. 1496-1501
-
-
Salonen, E.M.1
Vartio, T.2
Hedman, K.3
-
17
-
-
0028143826
-
Differential susceptibility of plasma proteins to oxidative modification: Examination by western blot immunoassay
-
Shacter E, Williams JA, Lim M, et al. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 1994; 17: 429-437.
-
(1994)
Free Radic Biol Med
, vol.17
, pp. 429-437
-
-
Shacter, E.1
Williams, J.A.2
Lim, M.3
-
18
-
-
21344453992
-
The influence of type 2 diabetes on fibrin structure and function
-
Dunn EJ, Ariëns RA, Grant PJ. The influence of type 2 diabetes on fibrin structure and function. Diabetologica 2005; 48: 1198-1206.
-
(2005)
Diabetologica
, vol.48
, pp. 1198-1206
-
-
Dunn, E.J.1
Ariëns, R.A.2
Grant, P.J.3
-
19
-
-
0029562794
-
The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator
-
Williams S, Fatah K, Ivert T, et al. The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator. Blood Coagul Fibrinolysis 1995; 6: 718-725.
-
(1995)
Blood Coagul Fibrinolysis
, vol.6
, pp. 718-725
-
-
Williams, S.1
Fatah, K.2
Ivert, T.3
-
20
-
-
33744994082
-
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
-
Mancini GB, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2006; 47: 2554-2560.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2554-2560
-
-
Mancini, G.B.1
Etminan, M.2
Zhang, B.3
-
21
-
-
0037044451
-
Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease
-
Mills JD, Ariens RA, Mansfield MW, et al. Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation. 2002; 106: 1938-1942.
-
(2002)
Circulation
, vol.106
, pp. 1938-1942
-
-
Mills, J.D.1
Ariens, R.A.2
Mansfield, M.W.3
-
22
-
-
0032728127
-
Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: Influence of plasma biochemical modifications
-
Collet J-P, Mishal Z, Lesty C, et al. Abnormal fibrin clot architecture in nephritic patients is related to hypofibrinolysis: influence of plasma biochemical modifications. Thromb Haemost 1999; 82: 1482-1489.
-
(1999)
Thromb Haemost
, vol.82
, pp. 1482-1489
-
-
Collet, J.-P.1
Mishal, Z.2
Lesty, C.3
-
23
-
-
33750209018
-
Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis
-
Collet J-P, Allali Y, Lesty C, et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-2573.
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 2567-2573
-
-
Collet, J.-P.1
Allali, Y.2
Lesty, C.3
-
24
-
-
67650463092
-
Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l
-
Undas A, Topor-Madry R, Tracz W. Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l. Pol Arch Med Wewn. 2009; 119: 354-359.
-
(2009)
Pol Arch Med Wewn
, vol.119
, pp. 354-359
-
-
Undas, A.1
Topor-Madry, R.2
Tracz, W.3
-
25
-
-
0036802128
-
Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk
-
Gonbert S, Malinsky S, Sposito AC, et al. Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. Atherosclerosis 2002; 164: 305-311.
-
(2002)
Atherosclerosis
, vol.164
, pp. 305-311
-
-
Gonbert, S.1
Malinsky, S.2
Sposito, A.C.3
-
26
-
-
65549089130
-
Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension
-
Lee TM, Chen CC, Shan HN, et al. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Clin Sci (Lond) 2009; 116: 497-505.
-
(2009)
Clin Sci (Lond)
, vol.116
, pp. 497-505
-
-
Lee, T.M.1
Chen, C.C.2
Shan, H.N.3
-
27
-
-
34548669619
-
Cardiovascular risk in chronic obstructive pulmonary disease
-
Maclay JD, McAlister DA, MacNee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12: 634-641.
-
(2007)
Respirology
, vol.12
, pp. 634-641
-
-
Maclay, J.D.1
McAlister, D.A.2
MacNee, W.3
-
28
-
-
33846008765
-
Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: Beneficial effects of statins
-
Lahera V, Goicoechea M, de Vinuesa SG, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem 2007; 14: 243-248.
-
(2007)
Curr Med Chem
, vol.14
, pp. 243-248
-
-
Lahera, V.1
Goicoechea, M.2
de Vinuesa, S.G.3
-
29
-
-
38349133637
-
Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress
-
Undas A, Szuldrzynski K, Stepien E, et al. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 2007; 196:551-558.
-
(2007)
Atherosclerosis
, vol.196
, pp. 551-558
-
-
Undas, A.1
Szuldrzynski, K.2
Stepien, E.3
-
30
-
-
0036209320
-
Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease
-
Ashitani J, Mukae H, Arimura Y, et al. Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease. Int Medicine 2002; 41: 181-185.
-
(2002)
Int Medicine
, vol.41
, pp. 181-185
-
-
Ashitani, J.1
Mukae, H.2
Arimura, Y.3
-
31
-
-
33747600439
-
Systemic inflammation in patients with COPD and pulmonary hypertension
-
Joppa P, Petrasova D, Stancak B, et al. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006; 130: 326-333.
-
(2006)
Chest
, vol.130
, pp. 326-333
-
-
Joppa, P.1
Petrasova, D.2
Stancak, B.3
-
32
-
-
0008706178
-
Sclerosis of pulmonary artery with thrombosis
-
Brenner O, Birm MD, Long M. Sclerosis of pulmonary artery with thrombosis. Lancet 1931; 1: 911-914.
-
(1931)
Lancet
, vol.1
, pp. 911-914
-
-
Brenner, O.1
Birm, M.D.2
Long, M.3
-
33
-
-
26244467021
-
C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: Evidence that CRP is prothrombotic
-
Singh U, Deveraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that CRP is prothrombotic. Arterioscler Thromb Vasc Biol 2005; 25: 2216-2221.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2216-2221
-
-
Singh, U.1
Deveraj, S.2
Jialal, I.3
|